Back to search
FDAFDA · Food and drugs·Recall number Z-2721-2024

LVP Primary Administration Set, Dual-Inlet, Low-Sorbing, Needle-Free Port, Y-Site (Qty 25), Product Code: SET-0013-25. for intravenous infusion.

Published September 11, 2024 · Recall initiated: August 1, 2024

Summary

FDA records medical device Class I recall Z-2721-2024, published September 11, 2024 and initiated August 1, 2024. Recalling firm: Fresenius Kabi USA, LLC; Status: Ongoing; Reported quantity: 180 cases/4,500 pieces; Lot: Product Code: SET-0013-25; UDI-DI: 00811505030054; Lot number: 3010538. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

A defect may cause an uncontrolled medication flow condition which may result in a dose greater than prescribed for the patient (i.e., medication overdose).

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fresenius Kabi USA, LLC
Distributor
US Distribution to states of: CO, ID, NJ, UT.
Lot
Product Code: SET-0013-25; UDI-DI: 00811505030054; Lot number: 3010538.
Risk classification
Class I
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was LVP Primary Administration Set, Dual-Inlet, Low-Sorbing, Needle-Free Port, Y-Site (Qty 25), Product Code: SET-0013-25. for intravenous infusion. recalled?

Yes. FDA published recall Z-2721-2024 on September 11, 2024. Reported hazard: A defect may cause an uncontrolled medication flow condition which may result in a dose greater than prescribed for the patient (i.e., medication overdose).

What should I do if I have this product?

Voluntary: Firm initiated · Telephone